Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio Inc. will go private. A full 87%...
3SBio has acquired the China rights to a...
3SBio of China out-licensed rights for...
3SBio Inc. in-licensed China rights to a...
3SBio, a Shenyang-based biopharma,...
3SBio of Shenyang has in-licensed rights...
China's 3SBio signed a second deal to...
3SBio of Shenyang acquired Sirton...
After two years as a private company,...
After going private two years ago, 3SBio...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
